AFL vs CODX · P/E 14, rev $18.93B vs rev $3.9M
Aflac Incorporated (AFL) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. CODX currently screens at market cap $31.4M.
Not investment advice. Open the AFL and CODX stock pages for the full models.
Not investment advice.